Press Releases

WASHINGTON, Dec. 9, 2019 /PRNewswire/ -- The National Resident Matching Program® (NRMP®) has released the results of the 2019 Medical Specialties Matching Program (MSMP). The MSMP encompasses nearly all Internal Medicine subspecialties, and the 2019 Match (for appointment Year 2020) surpassed the 2018 Match to become the largest in

SEATTLE, Dec. 9, 2019 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC) today announced the presentation of data from the Company's pacritinib development progr

WELLESLEY, Mass., Dec. 9, 2019 /PRNewswire/ -- Cure Alzheimer's Fund is pleased to announce the appointment of Morgan Herman as Executive Vice President. "We are delighted to welcome Morgan on board," said Timothy Armour, Cure Alzheimer's Fund's President and CEO. "She brings outstanding experience in health-relat

NEW YORK, Dec. 9, 2019 /PRNewswire/ -- EmblemHealth, one of the nation's largest non-profit health insurers, announced today that its affiliate primary and specialty care provider, BronxDocs, has opened its third location in the Bronx at 2044 Westchester Avenue. BronxDocs is an award-winning, multispecialty medical practice serving the

MINNEAPOLIS, Dec. 9, 2019 /PRNewswire/ -- Life Time, the nation's premier healthy lifestyle brand, continues to evolve its best-in-class programming with three new formats, including its lates

KING OF PRUSSIA, Pa. and ATLANTA, Dec. 9, 2019 /PRNewswire/ -- Genomind®, the leading mental health company, and Sharecare, the digital health company that help

WOODCLIFF LAKE, N.J., Dec. 9, 2019 /PRNewswire/ -- Eisai Inc. presented the latest healthcare economic (HCEI) data for FYCOMPA® (perampanel) CIII at the 2019 American Epilepsy Society Annual Meeting in Baltimore, Maryland. Cumulatively, more than 35 scientific abstracts on FYCOMPA were presented by both Eisai and indep

SAN FRANCISCO, Dec. 9, 2019 /PRNewswire/ -- Nektar Therapeutics (NASDAQ: NKTR) today announced three presentations at the 61st American Society of Hematology (ASH) Annual Meeting & Exposition for its IL-15 agonist and investigational candidate, NKTR-255. Data were presented from a number of preclinical studies conducted in collaboration with researche

CAMBRIDGE, Mass., Dec. 9, 2019 /PRNewswire/ -- Kymera Therapeutics Inc., a biotechnology company pioneering targeted protein degradation to discover breakthrough medicines for patients, today announced the company will present new preclinical data showing the further characterization of novel, highly selective and potent degraders of STAT3 with activity across multiple h

WASHINGTON, Dec. 9, 2019 /PRNewswire/ -- Leading global children's health organization, La Chaine de l'Espoir, announces the growth of its international network with the establishment of the Washington-based nonprofit United Surgeons for Children. The organization will be integral in building an American network of individuals, foundation